- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT06918119
Transkutan rygmarvstimulering for børn og unge med spina bifida
Karakterisering af transkutan rygmarvsstimulering til muliggørelse af refleksmotor fremkaldte svar hos børn og unge med spina bifida
A study to use transcutaneous spinal cord stimulation to characterize sensorimotor deficits in a pediatric population of individuals with spina bifida.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The study's goals involve understanding how transcutaneous stimulation affects motor deficits across three dimensions; weakness, coordination, and spasticity. This will be investigated by an electrophysiological characterization lower-extremity deficits, using TS to interrogate neuromotor topography and connectivity of the spinal cord to specific muscles. These evaluations will enable a unique patient-specific understanding of the electrophysiological mechanisms underlying motor deficits. Furthermore, these evaluations will assess the therapeutic potential of a novel closed-loop TS plasticity induction protocol to strengthen weakened muscles in a pediatric SB population.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Candee Mills
- Telefonnummer: 507-255-7253
- E-mail: Mills.Candee@mayo.edu
Studiesteder
-
-
Minnesota
-
Rochester, Minnesota, Forenede Stater, 55905
- Rekruttering
- Mayo Clinic in Rochester
-
Kontakt:
- Kristin D Zhao, Ph.D
- Telefonnummer: 507-284-8942
- E-mail: Zhao.Kristin@mayo.edu
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria
- Congenital diagnosis of myelomeningocele (MMC)
- Able to follow verbal commands or instructions.
- If female and able to become pregnant, must be willing to use medically-acceptable method of contraception during study participation.
Exclusion Criteria
- Severe cognitive deficits demonstrating inability to communicate needs
- Gaping, weeping, or unhealed open wounds at the site of electrode placement
- Unhealed fractures on load bearing bones
- History of osteoporosis
- History of implanted electronic devices at the stimulation location(e.g. deep brain stimulator, cardiac pacemaker, diaphragmatic pacer, baclofen pumps, insulin pumps, etc.)
- Pregnancy
- Epilepsy
- History of seizure
- Ongoing infections (currently being treated or are symptomatic)
- Any illness or condition which, based on the research team's assessment, will compromise the patient's ability to comply with the protocol, patient safety, or the validity of the data collected during this study.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: Ikke-randomiseret
- Interventionel model: Sekventiel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Functional motor training with transcutaneous spinal cord stimulation
Transcutaneous spinal cord stimulation will be delivered to the skin over the lower thoracic and lumbar spine region using adhesive electrodes for ages 5-11 for one multi-hour visit. The effects of stimulation will be recorded via electrophysiological and biomechanical metrics described within the outcomes measures. |
DS8R (Digitimer LLC) for transcutaneous neurostimulation. |
|
Eksperimentel: Extended functional motor training with transcutaneous spinal cord stimulation
An extended functional training arm for a subset of 10 subjects, ages 12-18, in which they will receive up to twelve multi-hour sessions of a therapeutic neuromuscular strengthening intervention within a 6 week period. |
DS8R (Digitimer LLC) for transcutaneous neurostimulation. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Manual muscle testing (MMT)
Tidsramme: 1 to 12 visits (up to 6 weeks)
|
Measuring muscle strength and function using the Daniels and Worthingham's Muscle Grading Scale. A physical therapist will use a 5-point scale to manually test the 5 lower extremity muscles on each side, with 0 being no visible or palpable contraction, up to 5 being full range of motion against gravity with maximal resistance. The maximum total score would be 50. |
1 to 12 visits (up to 6 weeks)
|
|
Spasticity (1)
Tidsramme: 1 to 12 visits (up to 6 weeks)
|
Change in measurement of leg muscle tone utilizing the Modified Ashworth Scale (MAS). A physical therapist will use a 5-point scale to assess resistance of major muscles during passive range of motion, with a lower score for a muscle indicating less tone. MAS for 4 muscle groups in each leg will be reported. |
1 to 12 visits (up to 6 weeks)
|
|
Spasticity (2)
Tidsramme: 1 to 12 visits (up to 6 weeks)
|
Change in measurements of leg muscle tone utilizing Wartenberg's pendulum test, with the first swing angle (FSA) degrees as the primary outcome. Fewer degrees on swing angle indicating greater spasticity. |
1 to 12 visits (up to 6 weeks)
|
|
Gait
Tidsramme: 1 to 12 visits (up to 6 weeks)
|
Gait speed will be quantified in m/sec utilizing a motion capture system, with faster gait speed indicating less impairment. |
1 to 12 visits (up to 6 weeks)
|
|
Coordination
Tidsramme: 1 to 12 visits (up to 6 weeks)
|
Coordination will be reported with the Selective Control Assessment of the Lower Extremity (SCALE) total limb score for both right and left leg. Total score for each limb is 10, with a higher score indicating coordination closer to optimal. |
1 to 12 visits (up to 6 weeks)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Electromyography (EMG)
Tidsramme: 1 to 12 visits (up to 6 weeks)
|
TS-evoked motor potential (MEP) amplitude, in millivolts, will be reported for major lower limbs muscles. An increase in MEP amplitude is indicative of greater muscle activation, closer to optimal function. |
1 to 12 visits (up to 6 weeks)
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Kristin Zhao, Ph.D., Mayo Clinic
- Ledende efterforsker: Joline Brandenburg, M.D., Mayo Clinic
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Sygdomme i nervesystemet
- Medfødte abnormiteter
- Misdannelser i nervesystemet
- Neuralrørsdefekter
- Medfødte, arvelige og neonatale sygdomme og abnormiteter
- Spinal dysrafi
- Meningomyelocele
- Terapeutik
- Fysioterapimodaliteter
- Rehabilitering
- Anæstesi og analgesi
- Elektrisk stimuleringsterapi
- Analgesi
- Transkutan elektrisk nervestimulering
Andre undersøgelses-id-numre
- 24-006063
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
There are no plans to share individual participant data.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .